1,995
Views
21
CrossRef citations to date
0
Altmetric
Editorial

ALSUntangled (ALSU): A Scientific Approach to Off-Label Treatment Options for People with ALS Using Tweets and Twitters

Pages 129-130 | Published online: 13 Aug 2009

References

  • Wasner K, Klier H, Borasio G. The use of alternative medicine by patients with amyotrophic lateral sclerosis. J Neurol Sci 2001; 191: 151–54
  • Bedlack RS, Pastula DM, Welsh E, Pulley D, Cudkowicz M. Scrutinizing enrollment in ALS clinical trials: Room for improvement?. Amyotroph Lateral Scler. 2008; 9: 257–65
  • Bedlack RS, Silani V, Cudkowicz M. IPLEX and the telephone game: the difficulty in separating myth from reality on the internet. Amyotroph Lateral Scler 2009;10:182–84.
  • van den Berg L. Unproven cell based treatments for ALS/MND: Lessons from Beijing. Amyotroph Lateral Scler. 2007; 8(S1)32
  • Sakowski SA, Schuyler AD, Feldman EL. Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. Apr 2009; 10: 63–73
  • Twitter.com [home page on the internet]. The website twitter; 2009 [cited 2009 April 13]. Main section [1 screen]. Available from http://search.twitter.com.
  • Search.twitter.com [home page on the internet]. The website twitter search; 2009 [cited 2009 April 13]. Main section [1 page]. Available from http://search.twitter.com.
  • Wfnals.org [home page on the internet]. The website of the world federation of neurology research group on ALS; 2009 [cited 2009 April 13]; Main section [1 page]. Available from http://www.wfnals.org.
  • Ning.com [home page on the internet]. The website ning; 2009 [cited 2009 April 13]. Main section [1 page]. Available from www.ning.com.
  • Facebook.com [home page on the internet]. The website facebook; 2009 [cited 2009 April 13]. Main section [1 page]. Available from www.facebook.com.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.